How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+Breast Cancer

被引:9
作者
Blaes, Anne [1 ]
Manisty, Charlotte [2 ,3 ]
Barac, Ana [4 ]
机构
[1] Univ Minnesota, Div Hematol Oncol, Minneapolis, MN USA
[2] UCL, London, England
[3] Barts Hlth NHS Trust, Div Cardiol, London, England
[4] Georgetown Univ, MedStar Heart & Vasc Inst, Cardiooncol Program, Washington, DC USA
关键词
breast cancer; cardiotoxicity; LV dysfunction; heart failure; HER2 targeted therapy; trastuzumab; AMERICAN SOCIETY; ECHOCARDIOGRAPHY; TRASTUZUMAB; PREVENTION; THERAPY;
D O I
10.1016/j.jaccao.2020.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:661 / 665
页数:5
相关论文
共 9 条
[1]   Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline [J].
Armenian, Saro H. ;
Lacchetti, Christina ;
Barac, Ana ;
Carver, Joseph ;
Constine, Louis S. ;
Denduluri, Neelima ;
Dent, Susan ;
Douglas, Pamela S. ;
Durand, Jean-Bernard ;
Ewer, Michael ;
Fabian, Carol ;
Hudson, Melissa ;
Jessup, Mariell ;
Jones, Lee W. ;
Ky, Bonnie ;
Mayer, Erica L. ;
Moslehi, Javid ;
Oeffinger, Kevin ;
Ray, Katharine ;
Ruddy, Kathryn ;
Lenihan, Daniel .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) :893-U144
[2]   Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy End of One Size Fits All [J].
Barac, Ana ;
Blaes, Anne ;
Lynce, Filipa .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (22) :2869-2871
[3]   Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer [J].
Dang, Chau ;
Guo, Hao ;
Najita, Julie ;
Yardley, Denise ;
Marcom, Kelly ;
Albain, Kathy ;
Rugo, Hope ;
Miller, Kathy ;
Ellis, Matthew ;
Shapira, Iuliana ;
Wolff, Antonio C. ;
Carey, Lisa A. ;
Moy, Beverly ;
Groarke, John ;
Moslehi, Javid ;
Krop, Ian ;
Burstein, Harold J. ;
Hudis, Clifford ;
Winter, Eric ;
Tolaney, Sara M. .
JAMA ONCOLOGY, 2016, 2 (01) :29-36
[4]   Left Ventricular Ejection Fraction Monitoring Adherence Rates Why So Low? [J].
Dang, Chau T. ;
Blaes, Anne ;
Lynce, Filipa ;
Swain, Sandra M. ;
Dent, Susan .
JACC-CARDIOVASCULAR IMAGING, 2018, 11 (08) :1094-1097
[5]   NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines [J].
Gradishar, William J. ;
Anderson, Benjamin O. ;
Balassanian, Ron ;
Blair, Sarah L. ;
Burstein, Harold J. ;
Cyr, Amy ;
Elias, Anthony D. ;
Farrar, William B. ;
Forero, Andres ;
Giordano, Sharon Hermes ;
Goetz, Matthew P. ;
Goldstein, Lori J. ;
Isakoff, Steven J. ;
Lyons, Janice ;
Marcom, P. Kelly ;
Mayer, Ingrid A. ;
McCormick, Beryl ;
Moran, Meena S. ;
O'Regan, Ruth M. ;
Patel, Sameer A. ;
Pierce, Lori J. ;
Reed, Elizabeth C. ;
Salerno, Kilian E. ;
Schwartzberg, Lee S. ;
Sitapati, Amy ;
Smith, Karen Lisa ;
Smith, Mary Lou ;
Soliman, Hatem ;
Somlo, George ;
Telli, Melinda ;
Ward, John H. ;
Shead, Dorothy A. ;
Kumar, Rashmi .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04) :433-+
[6]   Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity A Phase I Trial [J].
Leong, Darryl P. ;
Cosman, Tammy ;
Alhussein, Muhammad M. ;
Tyagi, Nidhi Kumar ;
Karampatos, Sarah ;
Barron, Carly C. ;
Wright, Douglas ;
Tandon, Vikas ;
Magloire, Patrick ;
Joseph, Philip ;
Conen, David ;
Devereaux, P. J. ;
Ellis, Peter M. ;
Mukherjee, Som D. ;
Dhesy-Thind, Sukhbinder .
JACC: CARDIOONCOLOGY, 2019, 1 (01) :1-10
[7]   Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study [J].
Lynce, F. ;
Barac, A. ;
Geng, X. ;
Dang, C. ;
Yu, A. F. ;
Smith, K. L. ;
Gallagher, C. ;
Pohlmann, P. R. ;
Nunes, R. ;
Herbolsheimer, P. ;
Warren, R. ;
Srichai, M. B. ;
Hofmeyer, M. ;
Cunningham, A. ;
Timothee, P. ;
Asch, F. M. ;
Shajahan-Haq, A. ;
Tan, M. T. ;
Isaacs, C. ;
Swain, S. M. .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (03) :595-603
[8]  
Plana JC, 2014, J AM SOC ECHOCARDIOG, V27, P911, DOI [10.1016/j.echo.2014.07.012, 10.1093/ehjci/jeu192]
[9]   Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab [J].
Sawaya, Heloisa ;
Sebag, Igal A. ;
Plana, Juan Carlos ;
Januzzi, James L. ;
Ky, Bonnie ;
Tan, Timothy C. ;
Cohen, Victor ;
Banchs, Jose ;
Carver, Joseph R. ;
Wiegers, Susan E. ;
Martin, Randolph P. ;
Picard, Michael H. ;
Gerszten, Robert E. ;
Halpern, Elkan F. ;
Passeri, Jonathan ;
Kuter, Irene ;
Scherrer-Crosbie, Marielle .
CIRCULATION-CARDIOVASCULAR IMAGING, 2012, 5 (05) :596-603